नई दवाइयाँ जो बदलेंगी Obesity का इलाज 💊 Orforglipron & Retatrutide | скачать в хорошем качестве

नई दवाइयाँ जो बदलेंगी Obesity का इलाज 💊 Orforglipron & Retatrutide |

Technology is reshaping the future of weight loss and diabetes care with its new pipeline drugs Retatrutide and Orforglipron (oral GLP-1). 🧪 In this video, Dr Anshuman Kaushal explains: ✅ What these drugs are and how they work ✅ Phase 2 & Phase 3 trial results with evidence ✅ Pros and cons compared to existing GLP-1 drugs ✅ Expected launch timelines globally and in India ✅ What this means for obesity and diabetes management ⚠️ Disclaimer “This video is for educational and informational purposes only. It is based on currently available scientific literature, including early phase clinical trial data. These medicines are still under research, not yet approved for routine clinical use, and may differ in safety, efficacy, and availability once final trials and regulatory reviews are completed. This is not medical advice. Always consult your physician or qualified healthcare professional before considering any treatment options. Never start, stop, or change your medications based on online information alone.